+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

2019 Aphasia Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

  • ID: 4767656
  • Report
  • April 2019
  • Region: Global
  • 83 pages
  • VPA Research
1 of 3

FEATURED COMPANIES

  • Axon Neuroscience SE
  • Berry Consultants LLC
  • Eisai Co Ltd
  • Johnson & Johnson
  • Novastem
  • Pfizer Inc
  • MORE
The global clinical trial report- “2019 Aphasia Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Aphasia. It presents in-depth analysis of Aphasia clinical trials across markets and companies. The research work is for providing complete understanding into trends in Aphasia.

The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.

It also segments the Aphasia clinical trials by:
  • Current Trial Status
  • Type of the trial
  • Sponsor Type
  • Enrollment Trends
  • Region
  • Countries
  • Trial Phase
The report also identifies the potential drug candidates under development for treatment of Aphasia

The research work is prepared through extensive and continuous research on Aphasia trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.

Report Scope and Coverage:
  • All major trials from 2010 to 2019 and planned trials are included in the report scope.
  • Drug candidates currently being researched for administering Aphasia patients are identified
  • The report includes panorama of Aphasia clinical trials across the globe
  • Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided
  • Companies and universities focusing on Aphasia clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)
  • Average Enrollment number, insights into enrollment trends, company wise enrollment are included
  • Both interventional and observational studies are analyzed
  • News and latest developments for the past one year are presented in the report
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Axon Neuroscience SE
  • Berry Consultants LLC
  • Eisai Co Ltd
  • Johnson & Johnson
  • Novastem
  • Pfizer Inc
  • MORE
1.1 List of Figures
1.2 List of Tables

2. Executive Summary
2.1 Aphasia Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
2.2.1 Aphasia Clinical Trials by Region
2.2.2 Average Enrollment of Aphasia Clinical Trials
2.2.3 Companies participating in Trials
2.2.4 Drugs under Study for Aphasia Treatment, 2019

3. Region wise Aphasia Clinical Trials
3.1 Asia Pacific Aphasia Clinical Trials by Country
3.2 Europe Aphasia Clinical Trials by Country
3.3 North America Aphasia Clinical Trials by Country
3.4 Middle East and Africa Aphasia Clinical Trials by Country
3.5 South and Central America Aphasia Clinical Trials by Country

4. Aphasia Clinical Trial Trends
4.1 Start Year wise Aphasia Clinical Trials
4.2 Phase wise Aphasia Clinical Trials
4.3 Trial Status wise Aphasia Clinical Trials
4.4 Trial Type wise Aphasia Clinical Trials

5. Aphasia Average Enrollment Trends
5.1 Average Enrollment in Aphasia Trials by Year
5.2 Average Enrollment in Aphasia Trials by Phase
5.3 Average Enrollment in Aphasia Trials by Status
5.4 Average Enrollment in Aphasia Trials by Type of Trial

6. Companies Participating in Aphasia Clinical Trials
6.1 Aphasia Trials by Sponsor Type
6.2 Aphasia Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7. Trial Snapshots- Phase, Type, Title, Location, Start Year, Completion Year, Recruitment Status, Enrollment, Participating Countries, Trial Locations, Company, Drugs and Other Details
7.1 Aphasia Trials- Phase 1
7.2 Aphasia Trials- Phase 2
7.3 Aphasia Trials- Phase 3
7.4 Aphasia Trials- Phase 4

8. Appendix
8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

List of Figures
Figure 1: Aphasia Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific - Country wise Aphasia Clinical Trials and Enrolment
Figure 5: Europe - Country wise Aphasia Clinical Trials and Enrolment
Figure 6: Middle East Africa - Country wise Aphasia Clinical Trials and Enrolment
Figure 7: North America - Country wise Aphasia Clinical Trials and Enrolment
Figure 8: South and Central America - Country wise Aphasia Clinical Trials and Enrolment
Figure 9: Aphasia Clinical Trials by Phase
Figure 10: Aphasia Clinical Trials by Trial Status
Figure 11: Aphasia Clinical Trials by Type
Figure 12: Aphasia Clinical Trials by Sponsor Type
Figure 13: Aphasia Clinical Trials by Leading Sponsors
Figure 14: Aphasia Average Enrollment by Phase
Figure 15: Aphasia Average Enrollment by Trial Status
Figure 16: Aphasia Average Enrollment by Type
Figure 17: Aphasia- Average Enrolment by Type of Sponsors
Figure 18: Aphasia- Enrolment by Leading Sponsors
Figure 19: Research Methodology

List of Tables
Table 1: Aphasia Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific - Country wise Aphasia Clinical Trials and Enrolment
Table 5: Europe - Country wise Aphasia Clinical Trials and Enrolment
Table 6: Middle East Africa - Country wise Aphasia Clinical Trials and Enrolment
Table 7: North America - Country wise Aphasia Clinical Trials and Enrolment
Table 8: South and Central America - Country wise Aphasia Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Aphasia Average Enrollment by Phase
Table 15: Aphasia Average Enrollment by Trial Status
Table 16: Aphasia Average Enrollment by Type
Table 17: Aphasia- Average Enrolment by Type of Sponsors
Table 18: Aphasia- Enrolment by Leading Sponsors
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Axon Neuroscience SE
  • Berry Consultants LLC
  • Eisai Co Ltd
  • Gabinete Berthier y Martinez
  • Johnson & Johnson
  • Novastem
  • Pfizer Inc
  • Shanxi Zhendong Pharmaceutical Co Ltd
  • TauRx Pharmaceuticals Ltd
  • The Lundbeck Foundation
Note: Product cover images may vary from those shown
Adroll
adroll